Pharmacology and clinical studies on erdafitinib: the first targeting therapeutic agent for the treatment of advanced or metastatic bladder cancer

LI Xiao; ZHANG Yan-hua

doi:10.3969/j.issn.1003-3734.2020.10.003

Home>Articles>Pharmacology and clinical studies on erdafitinib: the first targeting therapeutic agent for the treatment of advanced or metastatic bladder cancer

DOI: 10.3969/j.issn.1003-3734.2020.10.003

Pharmacology and clinical studies on erdafitinib: the first targeting therapeutic agent for the treatment of advanced or metastatic bladder cancer

LI Xiao

ZHANG Yan-hua

Machine-generated Keywords：

Publication Date：2020-05-31

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：4( 1093-1096 )

Chinese Journal of New Drugs

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2020,29(10)